Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

856 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[EFFICACY AND SAFETY OF ENFORTUMAB VEDOTIN IN ADVANCED UROTHELIAL CARCINOMA TREATMENT: AN INITIAL EXPERIENCE IN A SINGLE INSTITUTION].
Nishihara K, Kurose H, Ito N, Ohnishi S, Hirano T, Suekane H, Watanabe K, Chikui K, Ueda K, Uemura KI, Nakiri M, Suekane S, Igawa T. Nishihara K, et al. Among authors: ohnishi s. Nihon Hinyokika Gakkai Zasshi. 2024;115(1):21-27. doi: 10.5980/jpnjurol.115.21. Nihon Hinyokika Gakkai Zasshi. 2024. PMID: 39828344 Free article. Japanese.
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study.
Yang Z, Suda G, Sho T, Maehara O, Ohara M, Yoda T, Fu Q, Sasaki T, Kohya R, Yoshida S, Hosoda S, Kitagataya T, Kawagishi N, Nakai M, Natsuizaka M, Ogawa K, Ohnishi S, Yamamoto Y, Baba M, Yamada R, Kobayashi T, Chen M, Sakamoto N; NORTE Study Group. Yang Z, et al. Among authors: ohnishi s. Hepatol Res. 2024 Nov 25. doi: 10.1111/hepr.14139. Online ahead of print. Hepatol Res. 2024. PMID: 39584803
Hypoxic culture enhances the antimicrobial activity of amnion-derived mesenchymal stem cells, thereby reducing bacterial load and promoting wound healing in diabetic mice.
Ishii R, Ohnishi S, Hojo M, Ishikawa K, Funayama E, Miura T, Okubo N, Okada K, Yamamoto Y, Maeda T. Ishii R, et al. Among authors: ohnishi s. Biochem Biophys Res Commun. 2024 Dec 20;739:150903. doi: 10.1016/j.bbrc.2024.150903. Epub 2024 Oct 26. Biochem Biophys Res Commun. 2024. PMID: 39531904
Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC.
Yasuura N, Suda G, Ohara M, Meno A, Sho T, Kohya R, Sasaki T, Yoda T, Yoshida S, Fu Q, Yang Z, Hosoda S, Maehara O, Ohnishi S, Saitou T, Sugiyama M, Fukuhara T, Baba M, Kitagataya T, Kawagishi N, Nakai M, Natsuizaka M, Ogawa K, Taketomi A, Sakamoto N. Yasuura N, et al. Among authors: ohnishi s. Aliment Pharmacol Ther. 2024 Nov;60(10):1315-1324. doi: 10.1111/apt.18229. Epub 2024 Sep 4. Aliment Pharmacol Ther. 2024. PMID: 39228289
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.
Sho T, Suda G, Ohara M, Kohya R, Sasaki T, Yoshida S, Hosoda S, Ogawa K, Kitagataya T, Maehara O, Ohnishi S, Kawagishi N, Natsuizaka M, Nakai M, Baba M, Yamamoto Y, Tsukuda Y, Meguro T, Yamada R, Kobayashi T, Takagi T, Sakamoto N; NORTE STUDY GROUP. Sho T, et al. Among authors: ohnishi s. Target Oncol. 2024 Sep;19(5):769-778. doi: 10.1007/s11523-024-01092-7. Epub 2024 Sep 2. Target Oncol. 2024. PMID: 39222223
856 results